To the Editor: We appreciate Dr. Gase's drawing attention to the patient's experience during
opioid reduction. We agree with the importance of functional assessment, longitudinal …

Background: The opioid crisis presents many challenges for family practice providers in rural
communities who treat patients with chronic non-cancer pain (CNCP). Unfortunately …

Background: Opioid analgesics have been considered the drugs of choice for the treatment
of moderate to severe cancer and postoperative pain. Cultural attitudes and concerns about …

The opioid epidemic in the USA is now reaching other parts of the world (1–3). From 2001 to
2013, opioid use has more than doubled in North America and Europe (3). In the USA …

1980s, I was influenced by studies showing that physicians undertreated pain, and I vowed
that I would not practice in that way. Although many physicians I knew refused to enroll with …

to the editor: I enjoyed the excellent review on the management of chronic nonmalignant
pain, and would like to add that a limit on the maximal opioid dose should be set before …

EDITORIALS ent in long-term opioid use, and benefits are uncertain, Ed Covington of the
Cleveland Clinic stated that initiation of opioids for management of chronic pain should …

Approaches to management of chronic non-cancer pain and attitudes about opioid use
disorder vary widely among clinicians [1–3]. It is clear that we do not all agree on how to …

PURPOSE For clinicians, using opioid therapy for chronic noncancer pain (CNCP) often
gives rise to a conflict between treating their patients' pain and fears of addiction, diversion …

Introduction: The use of opioid medication for nonmalignant chronic pain (NMCP) increased
dramatically during the last 20 years. There have been regulatory changes implemented to …